|
1) Schachinger V, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1210-21
|
|
|
|
2) Lunde K, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1199-209
|
|
|
|
|
|
3) Rosenzweig A. Cardiac cell therapy--mixed results from mixed cells. N Engl J Med. 2006; 355: 1274-7
|
|
|
|
|
|
4) Assmus B, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006; 355: 1222-32
|
|
|
|
|
|
5) Menasche P, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008; 117: 1189-200
|
|
|
|
|
|
6) Caspi O, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007; 50: 1884-93
|
|
|
|
|
|
7) Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72
|
|
|
|
|
|
8) Oh H, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100: 12313-8
|
|
|
|
|
|
9) Messina E, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-21
|
|
|
|
|
|
10) Laugwitz KL, et al. Postnatal isl1＋ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005; 433: 647-53
|
|
|
|
|
|
11) Urbanek K, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A. 2006; 103: 9226-31
|
|
|
|
|
|
12) Tateishi K, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci. 2007; 120: 1791-800
|
|
|
|
|
|
13) Tateishi K, et al. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun. 2007; 352: 635-41
|
|
|
|
|
|
14) Smith RR, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007; 115: 896-908
|
|
|
|
|
|
15) Bearzi C, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007; 104: 14068-73
|
|
|
|
|
|
16) Pouly J, et al. Cardiac stem cells in the real world. J Thorac Cardiovasc Surg. 2008; 135: 673-8
|
|
|
|
|
|
17) Takehara N, Matsubara H, Oh H. Controlled Delivery of Basic Fibroblast Growth Factor Promotes Human Cardiosphere-Derived Cell Engraftment to Enhance Cardiac Repair for Chronic Myocardial Infarction. JACC. 2008; 52: 1858-65
|
|
|
|
|
|
18) Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7
|
|
|
|
|
|
19) Simons M, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002; 105: 788-93
|
|
|
|
|
|
20) Shim WS, et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun. 2004; 324: 481-8
|
|
|
|
|
|
21) Nygren JM, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004; 10: 494-501
|
|
|
|
|